← 產業報告目錄

Soft Tissue Repair Market by Product (Tissue Patches, Interference Screws, Xenografts, Suture Anchors, Laparoscopic Instruments), Application (Orthopedic, Skin, Dental), End User (Hospitals, Clinics, Ambulatory Surgery Centres) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-07-02頁數 276報告編號 MD3215

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The soft tissue repair market is projected to reach USD 20.5 million by 2030 from USD 15.9 million in 2025, growing at a CAGR of 5.1 % from 2025 to 2030. The rising demand for soft tissue repair is growing rapidly due to the increasing volume of surgeries and the growing prevalence of severe trauma injuries. The primary objective of soft tissue repair instruments and consumables is to fortify compromised tissue or surgically address torn or damaged soft tissue structures. The steady market growth in this sector can be attributed to several key factors, including the proliferation of innovative products across various subfields of soft tissue repair, the increasing incidence of sports-related injuries among the youth demographic, and the aging population, which is more prone to orthopedic soft tissue injuries and hernias. Moreover, advancements in healthcare infrastructure, coupled with heightened government investment in health systems and rising disposable incomes, particularly in Latin America and the Asia Pacific regions, are significantly propelling market expansion. However, challenges remain that could hinder progress, such as limited insurance reimbursements, intricate regulatory landscapes, and the high costs associated with surgical interventions. “By product, the tissue patches/meshes segment accounted for the largest market share in the soft tissue repair market in 2024.” The tissue patches/meshes segment commanded the largest share in the soft tissue repair market in 2024, primarily due to its extensive applications in hernia repair, pelvic organ prolapse, and various reconstructive procedures that necessitate the reinforcement or replacement of compromised soft tissues. The ascendancy of these products can be attributed to their structural support capabilities, reduced operative time, and improved patient outcomes. The rising adoption of both biologic and synthetic meshes, which exhibit enhanced integration with native tissues and a lower incidence of complications, has further fueled demand. Recent advancements in mesh technology, focusing on the development of lightweight, biocompatible, and absorbable polymers, have significantly bolstered their clinical acceptance and expanded their applications. Furthermore, the increasing prevalence of obesity, coupled with an aging demographic and a growing volume of surgeries requiring tissue reinforcement and reconstruction, contributes to the segment's robust growth. Moreover, the favorable reimbursement landscape for hernia and soft tissue repair procedures in developed markets enhances the adoption of patches and meshes, thereby solidifying their leading role within the product portfolio. “By application, the skin repair segment held the third-largest market share in the soft tissue repair market in 2024.” In the context of application types within the soft tissue repair market, skin repair represents the third-largest segment. A key factor influencing this segment is the high prevalence of chronic wounds, which necessitate effective skin repair interventions, such as those for diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The growing incidence of burn injuries and traumatic skin wounds further escalates the demand for advanced wound care and skin grafting solutions. Recent advancements in wound care technologies, including innovations in collagen dressings, growth factor therapies, and bioengineered skin substitutes, have markedly improved treatment efficacy. Moreover, heightened awareness among both patients and healthcare practitioners regarding the critical importance of timely wound management has played a substantial role in this market's expansion. Coupled with the increasing availability of insurance coverage for chronic wound care in many developed nations, these factors collectively contribute to the sustained growth of the skin repair segment within the broader soft tissue repair market. “By end user, the hospitals & clinics segment had the largest market share in the soft tissue repair market in 2024.” Hospitals and clinics dominate the market share largely due to their substantial patient throughput, which drives the demand for a wide spectrum of treatments ranging from routine procedures to complex surgical interventions. These institutions are often the primary access points for acute conditions such as trauma, sports-related injuries, and other ailments that require advanced soft tissue repair techniques. Equipped with highly qualified medical personnel and sophisticated infrastructure, hospitals often feature specialized departments—such as sports medicine, general surgery, and orthopedics—that enable comprehensive diagnostic capabilities and surgical interventions. Additionally, larger hospitals and comprehensive care clinics leverage economies of scale, allowing them to procure state-of-the-art surgical products and cutting-edge technologies. Their substantial funding and established relationships with leading medical device manufacturers enhance their ability to adopt and implement innovative solutions in patient care. “By region, Europe had the second-largest market share in the soft tissue repair market in 2024.” Europe is in the second leading position in the soft tissue repair market due to a combination of elements. A strong healthcare infrastructure backs the region, which facilitates widespread access to advanced surgical procedures and technologies. There is an unnatural need for soft tissue repair offerings brought about by the convergence of extensive age-related hernias and orthopedic diseases with a growing elderly population. European countries have strong reimbursement systems in place, along with favorable regulatory environments, which collectively encourage the uptake of innovative medical devices. The region is topped up by sustained funding for healthcare research, along with widespread adoption of early surgical techniques and the formation of leading medical device firms. The demand for soft tissue repair products in Europe has gained momentum with the increased awareness of patients and healthcare specialists regarding minimally invasive treatments and improved post-surgical results. A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below: • By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25% • By Designation: C-level–20%, Director Level 35%, and Others–45% • By Region: North America–27%, Europe–25%, Asia Pacific–30%, Others–18%. Key players in the Soft tissue repair market are Smith & Nephew (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic (IE), Lifenet Health, Inc. (US), Becton, Dickinson and Company (US), Integra Lifesciences Corporation (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK), Aroa Biosurgery Ltd. (NZ), Artivion Inc. (US), CONMED Corporation (US), Meril Lifesciences Pvt Ltd. (India), RTI Surgical (US), Samyang Holdings Corporation (South Korea), Acera Surgical Inc. (US), Orthocell Ltd. (Australia), Biocer Entwicklungs Gmbh (Germany), Isto Biologics (US), Betatech Medical (Turkey), and Mimedx (US) Research Coverage: The report analyzes the soft tissue repair market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes a competitive analysis of the key players in this market, along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall soft tissue repair market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: Analysis of key drivers (increasing geriatric population and obesity rate, rising incidence of sports injuries and trauma cases, growing focus on R&D for technologically advanced soft tissue repair product manufacturing, increasing volume of surgeries) restraints (unfavorable reimbursement scenario, high cost of advanced orthodontic treatment and surgical procedures) opportunities (growing adoption of regenerative medicine and biologics in emerging economies, increasing use of combination materials for enhancing product efficacy), challenges (stringent regulatory framework, shortage of skilled surgeons and specialized facilities) Market Penetration: The report includes extensive information on products offered by the major players in the global soft tissue repair market. It also includes various segments by product, application, end user, and region. Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global soft tissue repair market. Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region. Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global soft tissue repair market. Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global soft tissue repair market.
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 27 1.3.2 INCLUSIONS & EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 28 1.3.4 CURRENCY CONSIDERED 28 1.4 STAKEHOLDERS 29 1.5 SUMMARY OF CHANGES 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH APPROACH 30 2.1.1 SECONDARY DATA 30 2.1.1.1 Key sources of secondary data 31 2.1.1.2 Key data from secondary sources 32 2.1.2 PRIMARY DATA 32 2.1.2.1 Key primary sources 33 2.1.2.2 Key objectives of primary research 33 2.1.2.3 Key data from primary sources 34 2.1.2.4 Key industry insights 34 2.1.2.5 Breakdown of primaries 35 2.2 MARKET SIZE ESTIMATION 36 2.2.1 REVENUE SHARE ANALYSIS 36 2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 37 2.2.3 TOP-DOWN APPROACH (BASED ON UTILIZATION RATE AND ADOPTION PATTERN) 38 2.2.4 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 39 2.2.5 VOLUME ESTIMATION 39 2.3 GROWTH FORECAST 40 2.4 DATA TRIANGULATION 42 2.5 RESEARCH LIMITATIONS 43 2.5.1 SCOPE-RELATED LIMITATIONS 43 2.5.2 METHODOLOGY-RELATED LIMITATIONS 43 2.6 RISK ANALYSIS 43 2.7 STUDY ASSUMPTIONS 44 3 EXECUTIVE SUMMARY 45 4 PREMIUM INSIGHTS 49 4.1 SOFT TISSUE REPAIR MARKET OVERVIEW 49 4.2 SOFT TISSUE REPAIR MARKET: REGIONAL MIX 50 4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2024) 51 4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52 4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. EMERGING MARKETS 52 5 MARKET OVERVIEW 53 5.1 INTRODUCTION 53 5.2 MARKET DYNAMICS 53 5.2.1 DRIVERS 54 5.2.1.1 Increasing geriatric population and rising prevalence of obesity 54 5.2.1.2 Increasing occurrence of sports injuries 54 5.2.1.3 Rise in R&D investments and launch of technologically advanced products 55 5.2.1.4 High volume of surgeries and advancements in regenerative technologies 55 5.2.2 RESTRAINTS 57 5.2.2.1 Unfavorable reimbursement scenario 57 5.2.2.2 High cost of soft tissue repair products and surgical procedures 57 5.2.3 OPPORTUNITIES 58 5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging economies 58 5.2.3.2 Rising use of combination materials for enhancing product efficacy 59 5.2.4 CHALLENGES 59 5.2.4.1 Stringent regulatory framework 59 5.2.4.2 Requirement of skilled personnel for effective use of soft tissue repair products 60 5.3 ECOSYSTEM ANALYSIS 60 5.3.1 ROLE IN ECOSYSTEM 61 5.4 PRICING ANALYSIS 61 5.4.1 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024 61 5.4.2 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023 62 5.4.3 AVERAGE SELLING PRICE TREND OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024 62 5.5 SUPPLY CHAIN ANALYSIS 63 5.6 PATENT ANALYSIS 64 5.6.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET 64 5.6.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS 65 5.6.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN SOFT TISSUE REPAIR MARKET 66 5.6.4 LIST OF MAJOR PATENTS 66 5.7 VALUE CHAIN ANALYSIS 67 5.8 TECHNOLOGY ANALYSIS 68 5.8.1 KEY TECHNOLOGIES 68 5.8.1.1 Stem cell and regenerative therapies 68 5.8.1.2 Suture anchors and fixation devices 68 5.8.2 ADJACENT TECHNOLOGIES 68 5.8.2.1 3D bioprinting and tissue engineering 68 5.8.2.2 Regenerative medicine and biologics 69 5.8.3 COMPLEMENTARY TECHNOLOGIES 69 5.8.3.1 Wound closure and hemostatic devices 69 5.9 TRADE ANALYSIS 70 5.9.1 IMPORT DATA FOR HS CODE 300640, 2019–2023 70 5.9.2 EXPORT DATA FOR HS CODE 300640, 2019–2023 70 5.10 KEY CONFERENCES & EVENTS, 2025–2026 71 5.11 REGULATORY ANALYSIS 72 5.11.1 REGULATORY FRAMEWORK 72 5.11.1.1 North America 72 5.11.1.1.1 US 72 5.11.1.1.2 Canada 72 5.11.1.2 Europe 72 5.11.1.3 Asia Pacific 72 5.11.1.3.1 China 72 5.11.1.3.2 Japan 72 5.11.1.3.3 India 73 5.11.1.4 Latin America 73 5.11.1.4.1 Brazil 73 5.11.1.4.2 Mexico 73 5.11.1.5 Middle East 73 5.11.1.6 Africa 74 5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 74 5.12 PORTER’S FIVE FORCES ANALYSIS 76 5.12.1 THREAT OF NEW ENTRANTS 77 5.12.2 INTENSITY OF COMPETITIVE RIVALRY 78 5.12.3 BARGAINING POWER OF BUYERS 78 5.12.4 BARGAINING POWER OF SUPPLIERS 79 5.12.5 THREAT OF SUBSTITUTES 79 5.13 KEY STAKEHOLDERS & BUYING CRITERIA 79 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 79 5.13.2 KEY BUYING CRITERIA 80 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81   5.15 CASE STUDY ANALYSIS 82 5.15.1 TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS 82 5.15.2 TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC 82 5.15.3 HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX 83 5.16 INVESTMENT & FUNDING SCENARIO 83 5.17 REIMBURSEMENT SCENARIO ANALYSIS 84 5.18 END-USER EXPECTATIONS 84 5.19 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET 85 5.20 IMPACT OF 2025 US TARIFF ON SOFT TISSUE REPAIR MARKET 86 5.20.1 INTRODUCTION 86 5.20.2 KEY TARIFF RATES 87 5.20.3 PRICE IMPACT ANALYSIS 88 5.20.4 IMPACT ON END-USE INDUSTRIES 88 6 SOFT TISSUE REPAIR MARKET, BY PRODUCT 90 6.1 INTRODUCTION 91 6.2 TISSUE PATCHES/MESHES 91 6.2.1 SYNTHETIC MESHES 93 6.2.1.1 Cost-effectiveness and minimal risk of donor-to-host infectious disease transmission to aid market growth 93 6.2.2 BIOLOGICAL MESHES 95 6.2.2.1 Allografts 97 6.2.2.1.1 Better biocompatibility to fuel adoption in surgeries and organ transplants 97 6.2.2.2 Xenografts 98 6.2.2.2.1 Availability in multiple sizes to make xenografts more viable alternative in soft tissue repair procedures 98 6.2.3 FIXATION PRODUCTS 99 6.2.3.1 Suture anchors 101 6.2.3.1.1 Increasing number of soft tissue injuries and growing need for surgeries to augment segment growth 101 6.2.3.2 Interference screws 102 6.2.3.2.1 Rise in injuries among geriatric population and availability of biodegradable interference screws to drive segment 102 6.2.3.3 Other fixation products 103 6.3 LAPAROSCOPIC INSTRUMENTS 104 6.3.1 QUICKER RECOVERY TIME, DECREASED PAIN, LOWER INFECTION RATES, AND REDUCED DISEASE RECURRENCE TO DRIVE MARKET 104 6.4 OTHER PRODUCTS 105   7 SOFT TISSUE REPAIR MARKET, BY APPLICATION 106 7.1 INTRODUCTION 107 7.2 HERNIA REPAIR 107 7.2.1 RISING ADOPTION OF TENSION-FREE HERNIA REPAIR PROCEDURES TO FUEL MARKET GROWTH 107 7.3 SKIN REPAIR 109 7.3.1 RISING CASES OF BURN INJURIES TO SUPPORT MARKET GROWTH 109 7.4 ORTHOPEDIC SOFT TISSUE REPAIR 110 7.4.1 INCREASING SPORTS INJURIES AMONG ATHLETES AND RISING INCIDENCE OF ARTHRITIS IN ELDERLY TO FAVOR MARKET GROWTH 110 7.5 DENTAL SOFT TISSUE REPAIR 111 7.5.1 RISING NUMBER OF PREVENTIVE AND COSMETIC DENTAL PROCEDURES TO PROPEL MARKET GROWTH 111 7.6 BREAST RECONSTRUCTION 113 7.6.1 PREVALENCE OF BREAST CANCER AND INCREASING PATIENTS UNDERGOING MASTECTOMY TO AUGMENT MARKET GROWTH 113 7.7 DURAL REPAIR 114 7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS TO DRIVE MARKET 114 7.8 VAGINAL SLINGS 115 7.8.1 INCREASED OCCURRENCE OF STRESS-INDUCED URINARY INCONTINENCE (SUI) TO BOOST MARKET GROWTH 115 7.9 OTHER APPLICATIONS 116 8 SOFT TISSUE REPAIR MARKET, BY END USER 118 8.1 INTRODUCTION 119 8.2 HOSPITALS & CLINICS 119 8.2.1 RISING NUMBER OF REIMBURSED IN-PATIENT PROCEDURES TO DRIVE MARKET 119 8.3 AMBULATORY SURGICAL CENTERS 121 8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAY TO FUEL MARKET GROWTH 121 8.4 OTHER END USERS 122 9 SOFT TISSUE REPAIR MARKET, BY REGION 123 9.1 INTRODUCTION 124 9.2 NORTH AMERICA 125 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 125 9.2.2 US 129 9.2.2.1 US to dominate North American soft tissue repair market during forecast period 129 9.2.3 CANADA 131 9.2.3.1 High healthcare expenditure and favorable public & private funding to support market growth 131   9.3 EUROPE 134 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 135 9.3.2 GERMANY 138 9.3.2.1 Advanced healthcare infrastructure and favorable surgical reimbursement to propel market growth 138 9.3.3 FRANCE 140 9.3.3.1 Well-established healthcare system and high geriatric population to boost market growth 140 9.3.4 UK 143 9.3.4.1 Increasing hernia repair and cardiovascular surgeries to stimulate market growth 143 9.3.5 ITALY 146 9.3.5.1 Favorable government initiatives and high demand for surgical interventions to support market growth 146 9.3.6 SPAIN 148 9.3.6.1 Increasing healthcare budget and rising focus on local medical product manufacturing to drive market 148 9.3.7 REST OF EUROPE 151 9.4 ASIA PACIFIC 154 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 154 9.4.2 JAPAN 158 9.4.2.1 Strong healthcare system and high geriatric population to favor market growth 158 9.4.3 CHINA 161 9.4.3.1 Increasing number of hospitals and rising focus on healthcare policy reforms to stimulate market growth 161 9.4.4 INDIA 164 9.4.4.1 Greater healthcare awareness and increased government support to aid market growth 164 9.4.5 AUSTRALIA 167 9.4.5.1 Increasing government support and rising healthcare expenditure to support market growth 167 9.4.6 SOUTH KOREA 170 9.4.6.1 Advanced healthcare infrastructure and adoption of minimally invasive surgical technologies to fuel market growth 170 9.4.7 REST OF ASIA PACIFIC 173 9.5 LATIN AMERICA 175 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 176 9.5.2 BRAZIL 178 9.5.2.1 Strong public healthcare system and favorable government-led initiatives to aid market growth 178 9.5.3 MEXICO 181 9.5.3.1 Increased focus on healthcare modernization and surgical innovation to favor market growth 181 9.5.4 REST OF LATIN AMERICA 184   9.6 MIDDLE EAST & AFRICA 187 9.6.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE GOVERNMENT POLICIES TO DRIVE MARKET 187 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 188 9.7 GCC COUNTRIES 190 9.7.1 FOCUS ON MEDICAL TOURISM AND AVAILABILITY OF ADVANCED SURGICAL PROCEDURES TO AID MARKET GROWTH 190 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 191 10 COMPETITIVE LANDSCAPE 194 10.1 INTRODUCTION 194 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 194 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET 195 10.3 REVENUE ANALYSIS, 2020–2024 196 10.4 MARKET SHARE ANALYSIS, 2024 197 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 200 10.5.1 STARS 200 10.5.2 EMERGING LEADERS 200 10.5.3 PERVASIVE PLAYERS 200 10.5.4 PARTICIPANTS 200 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 202 10.5.5.1 Company footprint 202 10.5.5.2 Region footprint 203 10.5.5.3 Product footprint 204 10.5.5.4 Application footprint 205 10.5.5.5 End-user footprint 206 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 207 10.6.1 PROGRESSIVE COMPANIES 207 10.6.2 RESPONSIVE COMPANIES 207 10.6.3 DYNAMIC COMPANIES 207 10.6.4 STARTING BLOCKS 207 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 209 10.6.5.1 Detailed list of key startups/SMEs 209 10.6.5.2 Competitive benchmarking of startups/SMEs 210 10.7 COMPANY VALUATION & FINANCIAL METRICS 210 10.7.1 FINANCIAL METRICS 210 10.7.2 COMPANY VALUATION 211 10.8 R&D EXPENDITURE 211 10.9 BRAND/PRODUCT COMPARISON 212 10.10 COMPETITIVE SCENARIO 212 10.10.1 PRODUCT LAUNCHES 212 10.10.2 DEALS 213 10.10.3 EXPANSIONS 214 11 COMPANY PROFILES 215 11.1 KEY PLAYERS 215 11.1.1 ARTHREX, INC. 215 11.1.1.1 Business overview 215 11.1.1.2 Products offered 215 11.1.1.3 MnM view 217 11.1.1.3.1 Right to win 217 11.1.1.3.2 Strategic choices 217 11.1.1.3.3 Weaknesses & competitive threats 217 11.1.2 SMITH & NEPHEW PLC 218 11.1.2.1 Business overview 218 11.1.2.2 Products offered 219 11.1.2.3 Recent developments 220 11.1.2.3.1 Product launches 220 11.1.2.3.2 Deals 221 11.1.2.3.3 Expansions 221 11.1.2.4 MnM view 221 11.1.2.4.1 Right to win 221 11.1.2.4.2 Strategic choices 222 11.1.2.4.3 Weaknesses & competitive threats 222 11.1.3 JOHNSON & JOHNSON SERVICES, INC. 223 11.1.3.1 Business overview 223 11.1.3.2 Products offered 224 11.1.3.3 Recent developments 226 11.1.3.3.1 Deals 226 11.1.3.4 MnM view 226 11.1.3.4.1 Right to win 226 11.1.3.4.2 Strategic choices 226 11.1.3.4.3 Weaknesses & competitive threats 227 11.1.4 BECTON, DICKINSON AND COMPANY (BD) 228 11.1.4.1 Business overview 228 11.1.4.2 Products offered 229 11.1.4.3 MnM view 231 11.1.4.3.1 Right to win 231 11.1.4.3.2 Strategic choices 231 11.1.4.3.3 Weaknesses & competitive threats 231 11.1.5 STRYKER 232 11.1.5.1 Business overview 232 11.1.5.2 Products offered 233 11.1.5.3 MnM view 234 11.1.5.3.1 Right to win 234 11.1.5.3.2 Strategic choices 234 11.1.5.3.3 Weaknesses & competitive threats 234 11.1.6 MEDTRONIC 235 11.1.6.1 Business overview 235 11.1.6.2 Products offered 236 11.1.6.3 Recent developments 238 11.1.6.3.1 Deals 238 11.1.6.3.2 Expansions 238 11.1.6.3.3 Other developments 238 11.1.7 ZIMMER BIOMET 239 11.1.7.1 Business overview 239 11.1.7.2 Products offered 240 11.1.7.3 Recent developments 241 11.1.7.3.1 Deals 241 11.1.8 INTEGRA LIFESCIENCES CORPORATION 242 11.1.8.1 Business overview 242 11.1.8.2 Products offered 243 11.1.9 ARTIVION, INC. 245 11.1.9.1 Business overview 245 11.1.9.2 Products offered 246 11.1.10 ORGANOGENESIS INC. 248 11.1.10.1 Business overview 248 11.1.10.2 Products offered 249 11.1.11 LIFENET HEALTH 250 11.1.11.1 Business overview 250 11.1.11.2 Products offered 250 11.1.12 BAXTER 252 11.1.12.1 Business overview 252 11.1.12.2 Products offered 253 11.1.13 TISSUE REGENIX 254 11.1.13.1 Business overview 254 11.1.13.2 Products offered 255 11.1.14 CONMED CORPORATION 257 11.1.14.1 Business overview 257 11.1.14.2 Products offered 258 11.1.15 MERIL LIFE SCIENCES PVT. LTD. 260 11.1.15.1 Business overview 260 11.1.15.2 Products offered 260 11.1.16 RTI SURGICAL 261 11.1.16.1 Business overview 261 11.1.16.2 Products offered 261 11.2 OTHER PLAYERS 262 11.2.1 SAMYANG HOLDINGS CORPORATION 262 11.2.2 AROA BIOSURGERY LIMITED 263 11.2.3 ACERA SURGICAL INC. 263 11.2.4 ORTHOCELL LTD. 264 11.2.5 ACELL, INC. 264 11.2.6 BIOCER ENTWICKLUNGS-GMBH 265 11.2.7 ISTO BIOLOGICS 265 11.2.8 BETATECH MEDICAL 266 11.2.9 MIMEDX GROUP, INC. 267 12 APPENDIX 268 12.1 DISCUSSION GUIDE 268 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 272 12.3 CUSTOMIZATION OPTIONS 274 12.4 RELATED REPORTS 274 12.5 AUTHOR DETAILS 275
圖表清單 List of Tables & Figures
TABLE 1 SOFT TISSUE REPAIR MARKET: INCLUSIONS & EXCLUSIONS 28 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 29 TABLE 3 SOFT TISSUE REPAIR MARKET: RISK ANALYSIS 43 TABLE 4 SOFT TISSUE REPAIR MARKET: STUDY ASSUMPTIONS 44 TABLE 5 UK: INCREASE IN NUMBER OF CARDIAC SURGICAL PROCEDURES PERFORMED 56 TABLE 6 US VS. INDIA: COST OF SURGICAL PROCEDURES, 2023 (USD) 58 TABLE 7 SOFT TISSUE REPAIR MARKET: ROLE IN ECOSYSTEM 61 TABLE 8 AVERAGE SELLING PRICE TREND OF SYNTHETIC MESHES, BY REGION, 2022–2024 (USD) 61 TABLE 9 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS, BY TYPE, 2023 62 TABLE 10 AVERAGE SELLING PRICE OF SOFT TISSUE REPAIR PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 62 TABLE 11 SOFT TISSUE REPAIR MARKET: LIST OF MAJOR PATENTS 66 TABLE 12 IMPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 70 TABLE 13 EXPORT DATA FOR HS CODE 300640, BY COUNTRY, 2019–2023 (USD THOUSAND) 70 TABLE 14 SOFT TISSUE REPAIR MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 71 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 20 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES 76 TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 80 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 80 TABLE 23 CASE STUDY 1: TREATMENT OF CHRONIC SHOULDER INSTABILITY USING REGENETEN BIOINDUCTIVE IMPLANTS 82 TABLE 24 CASE STUDY 2: TREATMENT OF INCISIONAL HERNIA USING PARIETEX COMPOSITE VENTRAL PATCHES BY MEDTRONIC 82 TABLE 25 CASE STUDY 3: HEALING CHRONIC DIABETIC FOOT ULCERS WITH BILAYER WOUND MATRIX 83 TABLE 26 SOFT TISSUE REPAIR MARKET: END-USER EXPECTATIONS 84 TABLE 27 IMPACT OF AI/GEN AI ON SOFT TISSUE REPAIR MARKET 85 TABLE 28 US-ADJUSTED RECIPROCAL TARIFF RATES 87 TABLE 29 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91 TABLE 30 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 92 TABLE 31 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 32 SYNTHETIC MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 33 SYNTHETIC MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 95 TABLE 34 BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 95 TABLE 35 BIOLOGICAL MESHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 36 BIOLOGICAL MESHES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 97 TABLE 37 ALLOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 38 XENOGRAFTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 39 FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 100 TABLE 40 FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 41 SUTURE ANCHORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 42 INTERFERENCE SCREWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 43 OTHER FIXATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 44 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 45 SOFT TISSUE REPAIR MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 46 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 107 TABLE 47 HERNIA REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 48 SKIN REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 49 ORTHOPEDIC SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 50 DENTAL SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 51 BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 52 DURAL REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 53 VAGINAL SLINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 54 OTHER APPLICATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 55 SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 119 TABLE 56 SOFT TISSUE REPAIR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 57 SOFT TISSUE REPAIR MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 58 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 59 SOFT TISSUE REPAIR MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 60 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 61 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 127 TABLE 62 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 63 NORTH AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 64 NORTH AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 65 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 128 TABLE 66 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 128 TABLE 67 US: KEY MACROINDICATORS 129 TABLE 68 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 129 TABLE 69 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 70 US: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 71 US: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 72 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 73 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 131 TABLE 74 CANADA: KEY MACROINDICATORS 132 TABLE 75 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 132 TABLE 76 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 77 CANADA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 78 CANADA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 79 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 80 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 81 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 82 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 136 TABLE 83 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 84 EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 85 EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 86 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 87 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 88 GERMANY: KEY MACROINDICATORS 138 TABLE 89 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 138 TABLE 90 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 91 GERMANY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 92 GERMANY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 93 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 94 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 95 FRANCE: KEY MACROINDICATORS 141 TABLE 96 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 141 TABLE 97 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 98 FRANCE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 99 FRANCE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 100 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 101 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 102 UK: KEY MACROINDICATORS 143 TABLE 103 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 144 TABLE 104 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 105 UK: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 106 UK: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 107 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 108 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 109 ITALY: KEY MACROINDICATORS 146 TABLE 110 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146 TABLE 111 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 112 ITALY: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 113 ITALY: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 114 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148 TABLE 115 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 116 SPAIN: KEY MACROINDICATORS 149 TABLE 117 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 149 TABLE 118 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 119 SPAIN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 120 SPAIN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 121 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 122 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 123 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152 TABLE 124 REST OF EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 125 REST OF EUROPE: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 126 REST OF EUROPE: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 127 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 128 REST OF EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 129 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 130 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 131 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 132 ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 133 ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 134 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 135 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 136 JAPAN: KEY MACROINDICATORS 159 TABLE 137 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159 TABLE 138 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 139 JAPAN: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 140 JAPAN: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 141 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 142 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 161 TABLE 143 CHINA: KEY MACROINDICATORS 162 TABLE 144 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 145 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 146 CHINA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 147 CHINA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 148 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 149 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 150 INDIA: KEY MACROINDICATORS 165 TABLE 151 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 165 TABLE 152 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 153 INDIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 154 INDIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 155 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 156 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 157 AUSTRALIA: KEY MACROINDICATORS 168 TABLE 158 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 159 AUSTRALIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 160 AUSTRALIA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 161 AUSTRALIA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 162 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 163 AUSTRALIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 164 SOUTH KOREA: KEY MACROINDICATORS 171 TABLE 165 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 166 SOUTH KOREA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 167 SOUTH KOREA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 168 SOUTH KOREA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 169 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 170 SOUTH KOREA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 171 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 172 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 173 REST OF ASIA PACIFIC: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 174 REST OF ASIA PACIFIC: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 175 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 176 REST OF ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 177 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 178 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 176 TABLE 179 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 180 LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 181 LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 182 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178 TABLE 183 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 184 BRAZIL: KEY MACROINDICATORS 179 TABLE 185 BRAZIL: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179 TABLE 186 BRAZIL: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 187 BRAZIL: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 188 BRAZIL: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 189 BRAZIL: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 181 TABLE 190 BRAZIL: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 181 TABLE 191 MEXICO: KEY MACROINDICATORS 182 TABLE 192 MEXICO: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182 TABLE 193 MEXICO: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 194 MEXICO: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 195 MEXICO: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 196 MEXICO: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184 TABLE 197 MEXICO: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 198 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 199 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 200 REST OF LATIN AMERICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 201 REST OF LATIN AMERICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 202 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 186 TABLE 203 REST OF LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 204 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 205 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 206 MIDDLE EAST & AFRICA: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 207 MIDDLE EAST & AFRICA: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 208 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190 TABLE 209 MIDDLE EAST & AFRICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 210 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192 TABLE 211 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 212 GCC COUNTRIES: BIOLOGICAL MESHES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 213 GCC COUNTRIES: FIXATION PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 214 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 193 TABLE 215 GCC COUNTRIES: SOFT TISSUE REPAIR MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 216 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN SOFT TISSUE REPAIR MARKET 195 TABLE 217 SOFT TISSUE REPAIR MARKET: DEGREE OF COMPETITION 198 TABLE 218 SOFT TISSUE REPAIR MARKET: REGION FOOTPRINT 203 TABLE 219 SOFT TISSUE REPAIR MARKET: PRODUCT FOOTPRINT 204 TABLE 220 SOFT TISSUE REPAIR MARKET: APPLICATION FOOTPRINT 205 TABLE 221 SOFT TISSUE REPAIR MARKET: END-USER FOOTPRINT 206 TABLE 222 SOFT TISSUE REPAIR MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 209 TABLE 223 SOFT TISSUE REPAIR MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 210 TABLE 224 SOFT TISSUE REPAIR MARKET: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 212 TABLE 225 SOFT TISSUE REPAIR MARKET: DEALS, JANUARY 2022–APRIL 2025 213 TABLE 226 SOFT TISSUE REPAIR MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 214 TABLE 227 ARTHREX, INC.: COMPANY OVERVIEW 215 TABLE 228 ARTHREX, INC.: PRODUCTS OFFERED 215 TABLE 229 SMITH & NEPHEW PLC: COMPANY OVERVIEW 218 TABLE 230 SMITH & NEPHEW PLC: PRODUCTS OFFERED 219 TABLE 231 SMITH & NEPHEW PLC: PRODUCT LAUNCHES, JANUARY 2022–APRIL 2025 220 TABLE 232 SMITH & NEPHEW PLC: DEALS, JANUARY 2022–APRIL 2025 221 TABLE 233 SMITH & NEPHEW PLC: EXPANSIONS, JANUARY 2022–APRIL 2025 221 TABLE 234 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 223 TABLE 235 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 224 TABLE 236 JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2022–APRIL 2025 226 TABLE 237 BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW 228 TABLE 238 BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED 229 TABLE 239 STRYKER: COMPANY OVERVIEW 232 TABLE 240 STRYKER: PRODUCTS OFFERED 233 TABLE 241 MEDTRONIC: COMPANY OVERVIEW 235 TABLE 242 MEDTRONIC: PRODUCTS OFFERED 236 TABLE 243 MEDTRONIC: DEALS, JANUARY 2022–APRIL 2025 238 TABLE 244 MEDTRONIC: EXPANSIONS: JANUARY 2022–APRIL 2025 238 TABLE 245 MEDTRONIC: OTHER DEVELOPMENTS: JANUARY 2022–APRIL 2025 238 TABLE 246 ZIMMER BIOMET: COMPANY OVERVIEW 239 TABLE 247 ZIMMER BIOMET: PRODUCTS OFFERED 240 TABLE 248 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025 241 TABLE 249 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 242 TABLE 250 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 243 TABLE 251 ARTIVION, INC.: COMPANY OVERVIEW 245 TABLE 252 ARTIVION, INC.: PRODUCTS OFFERED 246 TABLE 253 ORGANOGENESIS INC.: COMPANY OVERVIEW 248 TABLE 254 ORGANOGENESIS INC.: PRODUCTS OFFERED 249 TABLE 255 LIFENET HEALTH: COMPANY OVERVIEW 250 TABLE 256 LIFENET HEALTH: PRODUCTS OFFERED 250 TABLE 257 BAXTER: COMPANY OVERVIEW 252 TABLE 258 BAXTER: PRODUCTS OFFERED 253 TABLE 259 TISSUE REGENIX: COMPANY OVERVIEW 254 TABLE 260 TISSUE REGENIX: PRODUCTS OFFERED 255 TABLE 261 CONMED CORPORATION: COMPANY OVERVIEW 257 TABLE 262 CONMED CORPORATION: PRODUCTS OFFERED 258 TABLE 263 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 260 TABLE 264 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 260 TABLE 265 RTI SURGICAL: COMPANY OVERVIEW 261 TABLE 266 RTI SURGICAL: PRODUCTS OFFERED 261 TABLE 267 SAMYANG HOLDINGS CORPORATION: COMPANY OVERVIEW 262 TABLE 268 AROA BIOSURGERY LIMITED: COMPANY OVERVIEW 263 TABLE 269 ACERA SURGICAL INC.: COMPANY OVERVIEW 263 TABLE 270 ORTHOCELL LTD.: COMPANY OVERVIEW 264 TABLE 271 ACELL, INC.: COMPANY OVERVIEW 264 TABLE 272 BIOCER ENTWICKLUNGS-GMBH: COMPANY OVERVIEW 265 TABLE 273 ISTO BIOLOGICS: COMPANY OVERVIEW 265 TABLE 274 BETATECH MEDICAL: COMPANY OVERVIEW 266 TABLE 275 MIMEDX GROUP, INC.: COMPANY OVERVIEW 267 FIGURE 1 SOFT TISSUE REPAIR MARKET SEGMENTATION & REGIONAL SCOPE 27 FIGURE 2 SOFT TISSUE REPAIR MARKET: YEARS CONSIDERED 28 FIGURE 3 SOFT TISSUE REPAIR MARKET: RESEARCH DESIGN 30 FIGURE 4 SOFT TISSUE REPAIR MARKET: KEY DATA FROM SECONDARY SOURCES 32 FIGURE 5 SOFT TISSUE REPAIR MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDE) 33 FIGURE 6 SOFT TISSUE REPAIR MARKET: KEY DATA FROM PRIMARY SOURCES 34 FIGURE 7 SOFT TISSUE REPAIR MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 34 FIGURE 8 BREAKDOWN OF PRIMARIES (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 35 FIGURE 9 BREAKDOWN OF PRIMARIES (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION 35 FIGURE 10 SOFT TISSUE REPAIR MARKET: MARKET SIZE ESTIMATION 36 FIGURE 11 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (SUPPLY SIDE) (2024) 37 FIGURE 12 SOFT TISSUE REPAIR MARKET: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH) (2024) 38 FIGURE 13 SOFT TISSUE REPAIR MARKET: TOP-DOWN APPROACH 39 FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SOFT TISSUE REPAIR MARKET 40 FIGURE 15 SOFT TISSUE REPAIR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) (2024) 41 FIGURE 16 SOFT TISSUE REPAIR MARKET: DATA TRIANGULATION 42 FIGURE 17 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 45 FIGURE 18 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 46 FIGURE 19 SOFT TISSUE REPAIR MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 20 REGIONAL SNAPSHOT OF SOFT TISSUE REPAIR MARKET 48 FIGURE 21 INCREASING NUMBER OF HERNIA REPAIR SURGERIES AND RISING R&D INVESTMENTS TO DRIVE MARKET 49 FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50 FIGURE 23 JAPAN AND TISSUE PATCHES/MESHES COMMANDED LARGEST MARKET SHARE IN 2024 51 FIGURE 24 CANADA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 52 FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 52 FIGURE 26 SOFT TISSUE REPAIR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53 FIGURE 27 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS 60 FIGURE 28 SOFT TISSUE REPAIR MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 29 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SOFT TISSUE REPAIR (JANUARY 2014–APRIL 2025) 65 FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES) FOR SOFT TISSUE REPAIR PATENTS, 2014–2025 66 FIGURE 31 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 32 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS 77 FIGURE 33 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 79 FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 80 FIGURE 35 SOFT TISSUE REPAIR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 81 FIGURE 36 SOFT TISSUE REPAIR MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024 83 FIGURE 37 SOFT TISSUE REPAIR MARKET: IMPACT OF AI/GEN AI 86 FIGURE 38 CANADA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 124 FIGURE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT 126 FIGURE 40 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT 155 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET, 2020–2024 197 FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SOFT TISSUE REPAIR MARKET (2024) 198 FIGURE 43 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 201 FIGURE 44 SOFT TISSUE REPAIR MARKET: COMPANY FOOTPRINT 202 FIGURE 45 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 208 FIGURE 46 EV/EBITDA OF KEY VENDORS 210 FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 211 FIGURE 48 SOFT TISSUE REPAIR MARKET: R&D EXPENDITURE OF KEY PLAYERS (2023 VS. 2024) 211 FIGURE 49 SOFT TISSUE REPAIR MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 212 FIGURE 50 SMITH & NEPHEW PLC: COMPANY SNAPSHOT 219 FIGURE 51 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 224 FIGURE 52 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT 228 FIGURE 53 STRYKER: COMPANY SNAPSHOT 233 FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT 236 FIGURE 55 ZIMMER BIOMET: COMPANY SNAPSHOT 240 FIGURE 56 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 243 FIGURE 57 ARTIVION, INC.: COMPANY SNAPSHOT 246 FIGURE 58 ORGANOGENESIS INC.: COMPANY SNAPSHOT 248 FIGURE 59 BAXTER: COMPANY SNAPSHOT 253 FIGURE 60 TISSUE REGENIX: COMPANY SNAPSHOT 255 FIGURE 61 CONMED CORPORATION: COMPANY SNAPSHOT 258

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們